Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Research Offers Insight into Diagnosis, Treatment of Small-Vessel Vasculitis

Susan Bernstein  |  Issue: March 2017  |  March 20, 2017

Although not common, some systemic diseases may cause secondary vasculitis, including systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome and dermatomyositis.

IgA vasculitis can be either primary or secondary, seems to be linked to infection and predominantly affects small vessels of the skin, joints, gastrointestinal tract and kidneys, she said. Often, patients have skin purpura and joint arthralgia.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“It’s the most common vasculitis in childhood, but it is rare in adults,” said Dr. Villa-Forte. “In children, it seems to have a seasonal pattern, more common in fall and winter, so it’s been linked to upper respiratory infections.” Adults with IgA vasculitis have worse renal outcomes, and the disease doesn’t seem to spontaneously remit as often as it does in children, she said.


Susan Bernstein is a freelance journalist based in Atlanta.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Miss Any of These Important Sessions?

If you missed any of these important sessions, find them on SessionSelect.

References

  1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheumatol. 2013 Jan;65(1):1–11.
  2. Jennette JC, Falk RJ, Bacon PA et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheumatol. 2013 Jan;65(1):1–11.
  3. Hoffman GS, Weyand CM, Langford CA, et al. Inflammatory diseases of blood vessels, second edition. Blackwell Publishing, Ltd. Published online 3 May 2012.
  4. Ananthakrishnan L, Sharma N, Kanne JP. Wegener’s granulomatosis in the chest: high-resolution CT findings. AJR Am J Roentgenol. 2009 Mar;192:676–682.
  5. Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets between ANCA-associated vasculitis. N Engl J Med. 2012 Jul 19;367(3):214–223.
  6. Lanham JG, Elkon KB, Pusey CD. Systemic vasculitis with asthma and eosinophilia: A clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984 Mar;63(2):65–81.
  7. Sinico RA, di Toma, L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum. 2005 Sep;52(9):2926–2935.
  8. Vassilopoulos D, Younossi ZM, Hadziyannis E, et al. Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations. Clin Exp Rheumatol. 2003;21(suppl 32):S100–S111.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsResearch RheumVasculitis Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)DiagnosisResearchRheumatic DiseaseVasculitis

Related Articles
    Figure 2: Renal Biopsy

    The Classification & Diagnosis of Granulomatosis with Polyangiitis

    August 16, 2018

    Based on the classification system developed by the Chapel Hill Consensus Conference, anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is defined as a necrotizing vasculitis involving small vessels that is associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA and displays minimal immune deposits. The mechanism behind the pathogenesis of ANCA-associated vasculitis is not fully…

    Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

    Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

    June 21, 2018

    Granulomatosis with polyangiitis (GPA) was first described in the British Medical Journal in 1897 by Scottish otolaryngologist Peter McBride.1 GPA is a relatively rare, systemic necrotizing vasculitis that can make diagnosis challenging. The incidence has been estimated anywhere between two and 12 cases per million.2 GPA mainly affects adults between the ages of 45 and…

    Vasculitis

    June 1, 2009

    A New perspective on when and how it begins

    Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

    February 16, 2021

    Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences